Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
Open Access
- 7 August 2017
- journal article
- case report
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 73 (11), 1459-1465
- https://doi.org/10.1007/s00228-017-2311-6
Abstract
Purpose A patient was identified with severe metabolic acidosis, a high anion gap and 5-oxoproline accumulation, probably caused by the simultaneous use of paracetamol (acetaminophen) and flucloxacillin. We wanted to investigate the necessity to control the interaction between both drugs with an automatic alert system. Methods To investigate the relevance of the interaction of paracetamol and flucloxacillin, a retrospective study was conducted. Data on paracetamol and flucloxacillin prescriptions and laboratory data (pH, Na+, HCO3 −, Cl−, albumin and 5-oxoproline levels) were combined to assess the prevalence of acidosis, calculate the anion gap and analyse 5-oxoproline levels in clinically admitted patients using both drugs simultaneously. Results In the 2-year study period, approximately 53,000 admissions took place in our hospital. One thousand and fifty-seven patients used paracetamol and flucloxacillin simultaneously, of which 51 patients (4.8%) had a serum pH ≤ 7.35. One patient, the same patient as presented in the case report, had a high anion gap and a toxic level of 5-oxoproline. Conclusion The prevalence of metabolic acidosis is very low and the only patient identified with the interaction was recognised during normal clinical care. We conclude that automatic alerts based on simultaneous use of paracetamol and flucloxacillin will generate too many signals. To recognise patients earlier and prevent severe outcomes, a warning system (clinical rule) based on paracetamol, flucloxacillin and pH measurement may be helpful. Early calculation of the anion gap can narrow the differential diagnosis of patients with metabolic acidosis and measurement of 5-oxoproline can explain acidosis due the interaction of paracetamol and flucloxacillin.Keywords
Funding Information
- Academic Medical Center (AMC)
This publication has 15 references indexed in Scilit:
- Metabolic acidosis and 5-oxoprolinuria induced by flucloxacillin and acetaminophen: a case reportJournal of Medical Case Reports, 2016
- The acetaminophen metabolite N-acetyl-p-benzoquinone imine (NAPQI) inhibits glutathione synthetasein vitro; a clue to the mechanism of 5-oxoprolinuric acidosis?Xenobiotica, 2016
- Pyroglutamic acid-induced metabolic acidosis: a case reportActa Clinica Belgica, 2014
- What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?Clinical Toxicology, 2013
- Severe Anion Gap Metabolic Acidosis From Acetaminophen Use Secondary to 5-Oxoproline (Pyroglutamic Acid) AccumulationThe American Journal of the Medical Sciences, 2012
- 5-Oxoprolinemia Causing Elevated Anion Gap Metabolic Acidosis in the Setting of Acetaminophen UseThe Journal of Emergency Medicine, 2011
- [Severe metabolic acidosis as a result of 5-oxoproline in acetaminophen use].2010
- Metabolic acidosis in the critically ill: Part 1. Classification and pathophysiologyAnaesthesia, 2008
- Serum Anion GapClinical Journal of the American Society of Nephrology, 2007
- Differing response of the glutathione system to fasting in neonatal and adult guinea pigsBiochemical Pharmacology, 1992